Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
Clinical trials sponsored by Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd., explained in plain language.
-
New Weight-Loss shot CPX101 shows promise in phase 2 trial
Disease control CompletedThis study tested a new drug called CPX101 to help people who are overweight or obese lose weight. The trial included 240 adults without diabetes who received either the drug or a placebo over 24 weeks. The main goal was to see how much weight they lost and if the drug was safe.
Phase: PHASE2 • Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New Weight-Loss drug CPX101 enters human testing
Symptom relief CompletedThis early-phase study tested a new drug called CPX101 in 72 healthy volunteers and overweight or obese patients. The main goal was to check if the drug is safe and tolerable, and to see how the body processes it. Researchers also looked at whether multiple doses could help with …
Phase: PHASE1 • Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC